Skip to main content

Table 7 Health-state specific QALYs

From: Cost-effectiveness of sofosbuvir-based treatments for chronic hepatitis C in the US

QALYs Baseline Range Reference
Uninfected 1 1 [27]
Chronic Hepatitis C 0.82 0.6-0.9 [27]
Compensated Cirrhosis 0.78 0.5-0.9 [27]
Decompensated Cirrhosis 0.65 0.3-0.88 [27]
HCC 0.25 0.1-0.5 [27]
Liver Transplant (1st year) 0.5 0.11-0.7 [27]
Liver Transplant (successive year) 0.7 0.24-0.87 [27]